Author:
Brie Daniel,Sahebkar Amirhossein,Penson Peter E.,Dinca Madalina,Ursoniu Sorin,Serban Maria-Corina,Zanchetti Alberto,Howard George,Ahmed Ali,Aronow Wilbert S.,Muntner Paul,Lip Gregory Y.H.,Wong Nathan D.,Rysz Jacek,Banach Maciej
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine
Reference52 articles.
1. Pentoxifylline for intermittent claudication;Salhiyyah;Cochrane Database Syst Rev,2012
2. Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases;Zhang;Exp Clin Cardiol,2004
3. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy;Ward;Drugs,1987
4. Pentoxifylline: a new drug for the treatment of intermittent claudication. Mechanism of action, pharmacokinetics, clinical efficacy and adverse effects;Aviado;Pharmacotherapy,1984
5. Differential regulation of TNFα, IL-1β, IL-6, IL-8, TNFβ, and IL-10 by pentoxifylline;D’Hellencourt;Int J Immunopharmacol,1996
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献